Complete Response Letters
Unicycive Therapeutics Inc.: oxylanthanum carbonate
What FDA's Complete Response Letters to the company say, in the letters' own words.
Complete Response Letter, Jun 29, 2026
The facility should provide satisfactory responses to hese deficiencies to the FDA office indicated on the FDA Form 483 prior to your complete response.
CRL_NDA218607_20260629:p1:s18Complete Response Letter, Jun 27, 2025
The facility should provide satisfactory responses to these deficiencies to the FDA office indicated on the FDA Form 483 prior to your complete response to your application.
CRL_NDA218607_20250627:p1:s17More Complete Response Letters
Updated Sep 30, 2026 · built from 283 companies in the EphemerisX knowledge graph. This page is regenerated as companies are added.